124 related articles for article (PubMed ID: 2071163)
1. A soluble factor from Trypanosoma brucei rhodesiense that prevents progression of activated human T lymphocytes through the cell cycle.
Sztein MB; Kierszenbaum F
Immunology; 1991 Jun; 73(2):180-5. PubMed ID: 2071163
[TBL] [Abstract][Full Text] [Related]
2. Molecular basis of Trypanosoma cruzi-induced immunosuppression. Altered expression by activated human lymphocytes of molecules which regulate antigen recognition and progression through the cell cycle.
Kierszenbaum F; Moretti E; Sztein MB
Biol Res; 1993; 26(1-2):197-207. PubMed ID: 7670532
[TBL] [Abstract][Full Text] [Related]
3. Suppression by Trypanosoma cruzi of T-cell receptor expression by activated human lymphocytes.
Sztein MB; Kierszenbaum F
Immunology; 1992 Oct; 77(2):277-83. PubMed ID: 1427979
[TBL] [Abstract][Full Text] [Related]
4. In vitro simulation of immunosuppression caused by Trypanosoma brucei.
Sileghem M; Darji A; De Baetselier P
Immunology; 1991 Jun; 73(2):246-8. PubMed ID: 2071169
[TBL] [Abstract][Full Text] [Related]
5. Trypanosomal immunosuppressive factor: a secretion product(s) of Trypanosoma cruzi that inhibits proliferation and IL-2 receptor expression by activated human peripheral blood mononuclear cells.
Kierszenbaum F; Cuna WR; Beltz LA; Sztein MB
J Immunol; 1990 May; 144(10):4000-4. PubMed ID: 2185317
[TBL] [Abstract][Full Text] [Related]
6. B lymphocytes of mice display an aberrant activation phenotype and are cell cycle arrested in G0/G1A during acute infection with Trypanosoma brucei.
Sacco RE; Hagen M; Donelson JE; Lynch RG
J Immunol; 1994 Aug; 153(4):1714-23. PubMed ID: 7519210
[TBL] [Abstract][Full Text] [Related]
7. Murine T lymphocyte specificity for African trypanosomes. I. Induction of a T lymphocyte-dependent proliferative response to Trypanosoma brucei.
Gasbarre LC; Hug K; Louis JA
Clin Exp Immunol; 1980 Jul; 41(1):97-106. PubMed ID: 6160003
[TBL] [Abstract][Full Text] [Related]
8. Novel mechanism for Trypanosoma cruzi-induced suppression of human lymphocytes. Inhibition of IL-2 receptor expression.
Beltz LA; Sztein MB; Kierszenbaum F
J Immunol; 1988 Jul; 141(1):289-94. PubMed ID: 3132504
[TBL] [Abstract][Full Text] [Related]
9. Suppression by Trypanosoma brucei rhodesiense of the capacities of human T lymphocytes to express interleukin-2 receptors and proliferate after mitogenic stimulation.
Kierszenbaum F; Muthukkumar S; Beltz LA; Sztein MB
Infect Immun; 1991 Oct; 59(10):3518-22. PubMed ID: 1894358
[TBL] [Abstract][Full Text] [Related]
10. The extracts from Nelumbo Nucifera suppress cell cycle progression, cytokine genes expression, and cell proliferation in human peripheral blood mononuclear cells.
Liu CP; Tsai WJ; Lin YL; Liao JF; Chen CF; Kuo YC
Life Sci; 2004 Jun; 75(6):699-716. PubMed ID: 15172179
[TBL] [Abstract][Full Text] [Related]
11. Trypanosoma cruzi inhibits the expression of CD3, CD4, CD8, and IL-2R by mitogen-activated helper and cytotoxic human lymphocytes.
Sztein MB; Cuna WR; Kierszenbaum F
J Immunol; 1990 May; 144(9):3558-62. PubMed ID: 2139458
[TBL] [Abstract][Full Text] [Related]
12. Bidirectional activating signals between Trypanosoma brucei and CD8+ T cells: a trypanosome-released factor triggers interferon-gamma production that stimulates parasite growth.
Olsson T; Bakhiet M; Edlund C; Höjeberg B; Van der Meide PH; Kristensson K
Eur J Immunol; 1991 Oct; 21(10):2447-54. PubMed ID: 1915554
[TBL] [Abstract][Full Text] [Related]
13. Suppressor macrophages in African trypanosomiasis inhibit T cell proliferative responses by nitric oxide and prostaglandins.
Schleifer KW; Mansfield JM
J Immunol; 1993 Nov; 151(10):5492-503. PubMed ID: 8228241
[TBL] [Abstract][Full Text] [Related]
14. Quantitative and qualitative signals determine T-cell cycle entry and progression.
Modiano JF; Mayor J; Ball C; Chitko-McKown CG; Sakata N; Domenico-Hahn J; Lucas JJ; Gelfand EW
Cell Immunol; 1999 Oct; 197(1):19-29. PubMed ID: 10555992
[TBL] [Abstract][Full Text] [Related]
15. Rapamycin blocks cell cycle progression of activated T cells prior to events characteristic of the middle to late G1 phase of the cycle.
Terada N; Lucas JJ; Szepesi A; Franklin RA; Domenico J; Gelfand EW
J Cell Physiol; 1993 Jan; 154(1):7-15. PubMed ID: 8419408
[TBL] [Abstract][Full Text] [Related]
16. Identification of a parasitic immunomodulatory protein triggering the development of suppressive M1 macrophages during African trypanosomiasis.
Gómez-Rodríguez J; Stijlemans B; De Muylder G; Korf H; Brys L; Berberof M; Darji A; Pays E; De Baetselier P; Beschin A
J Infect Dis; 2009 Dec; 200(12):1849-60. PubMed ID: 19911988
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms by which oxidative injury inhibits the proliferative response of human lymphocytes to PHA. Effect of the thiol compound 2-mercaptoethanol.
Gougerot-Pocidalo MA; Fay M; Roche Y; Chollet-Martin S
Immunology; 1988 Jun; 64(2):281-8. PubMed ID: 3391643
[TBL] [Abstract][Full Text] [Related]
18. Murine T lymphocyte specificity for African trypanosomes. II. Suppression of the T lymphocyte proliferative response to Trypanosoma brucei by systemic trypanosome infection.
Gasbarre LC; Hug K; Louis J
Clin Exp Immunol; 1981 Jul; 45(1):165-72. PubMed ID: 6458434
[TBL] [Abstract][Full Text] [Related]
19. Changes in activation markers and cell membrane receptors on human peripheral blood T lymphocytes during cell cycle progression after PHA stimulation.
Poulton TA; Gallagher A; Potts RC; Beck JS
Immunology; 1988 Jul; 64(3):419-25. PubMed ID: 3261709
[TBL] [Abstract][Full Text] [Related]
20. Endothelial cell activation in the presence of African trypanosomes.
Girard M; Giraud S; Courtioux B; Jauberteau-Marchan MO; Bouteille B
Mol Biochem Parasitol; 2005 Jan; 139(1):41-9. PubMed ID: 15610818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
